Venture Partners V. Lp Arch serves as Executive at Trubion Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Venture Partners V. Lp Arch has executed 8 insider transactions totaling $2.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 26, 2016 involved exercising options for 820,935 shares valued at $0.
Venture Partners V. Lp Arch currently holds 820,935 shares of Trubion Pharmaceuticals, Inc (TRBN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners V. Lp Arch has been a net buyer of TRBN stock. They have purchased $2.9M and sold $0 worth of shares.
Venture Partners V. Lp Arch's most recent insider trade was on Jul 26, 2016, when they sold 820,935 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 26, 2016 | PI | $298.6K | Exercise | 40,025 | $7.46 | Discretionary |
| Jul 26, 2016 | PI | $298.4K | Payment | 21,313 | $14.00 | Discretionary |
| Jul 21, 2011 | NGSX | $2.9M | Purchase | 1,744,186 | $1.65 | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 14,345 | $N/A | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 2,141,339 | $N/A | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 132,802 | $N/A | Discretionary |